Laser versus bleomycin for infant hemangioma

This study compares three approaches—pulsed-dye laser, timolol (a medicated skin solution), or watch-and-wait—to see which works best to slow the growth of a hemangioma birthmark in young babies. It may help find a treatment that shrinks or controls the birthmark as early as possible.

This study looks at babies with a common birthmark called infantile hemangioma (made of blood vessels) to help doctors decide the best treatment or whether monitoring is enough. It involves a first evaluation and follow-up, but no new drugs or procedures are tested.

This trial tests a medicine called bleomycin, injected into lymphatic malformations (abnormal fluid-filled growths) to shrink them. It is for children under 14 whose malformations are growing quickly, causing symptoms or problems, and cannot be removed by surgery alone.

This study compares two injected medicines, bleomycin and doxycycline, to see which works better for shrinking lymphatic malformations (abnormal fluid-filled cysts) in children. If your child qualifies, they would receive one of these treatments to help reduce the size of the cysts.

This study tests a treatment called bleomycin electrosclerotherapy (BEST) for people with low-flow vascular malformations—abnormal clusters of blood or lymph vessels that can cause pain or swelling. The treatment combines a drug (bleomycin) with a small electrical current to shrink these abnormal vessels, and the goal is to see if it helps when other treatments haven't worked well or the problem came back.

This study is testing a treatment called electrosclerotherapy for low-flow venous malformations. It uses a medicine (bleomycin) injected into the abnormal blood vessels to shrink them. The goal is to see how well it works and how safe it is.